ARTICLE | Product Development
Visibility for Europe's cancer plays
June 9, 2003 7:00 AM UTC
Lessons from ASCO
New cancer compounds from pharmaceutical companies and U.S. biotech companies are nearer to market, but European biotechs now can see the first real bolus of registration efforts on the horizon. ...